High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$2.5M
$2,474,225
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
MLYS
M
Mineralys Therapeutics, Inc.
Rodman David Malcom
• Officer • Chief Medical Officer
Other
2026-03-09
$34,736
|
||||||
| MLYS |
Mineralys Therapeutics, Inc.
|
Officer • Chief Medical Officer
Other
|
2026-03-09 | $34,736 | M | Form 4 |
|
MLYS
S
Mineralys Therapeutics, Inc.
Rodman David Malcom
• Officer • Chief Medical Officer
10b5-1 Sell
2026-03-09
$58,270
|
||||||
| MLYS |
Mineralys Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2026-03-09 | $58,270 | S | Form 4 |
|
MLYS
M
Mineralys Therapeutics, Inc.
Rodman David Malcom
• Officer • Chief Medical Officer
Other
2026-02-17
$6,438
|
||||||
| MLYS |
Mineralys Therapeutics, Inc.
|
Officer • Chief Medical Officer
Other
|
2026-02-17 | $6,438 | M | Form 4 |
|
MLYS
S
Mineralys Therapeutics, Inc.
Rodman David Malcom
• Officer • Chief Medical Officer
10b5-1 Sell
2026-02-17
$11,505
|
||||||
| MLYS |
Mineralys Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2026-02-17 | $11,505 | S | Form 4 |
|
MLYS
M
Mineralys Therapeutics, Inc.
Rodman David Malcom
• Officer • Chief Medical Officer
Other
2026-02-13
$95,484x2
|
||||||
| MLYS |
Mineralys Therapeutics, Inc.
|
Officer • Chief Medical Officer
Other
|
2026-02-13 | $95,484x2 | M | Form 4 |
|
MLYS
S
Mineralys Therapeutics, Inc.
Rodman David Malcom
• Officer • Chief Medical Officer
10b5-1 Sell
2026-02-13
$385,732x3
|
||||||
| MLYS |
Mineralys Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2026-02-13 | $385,732x3 | S | Form 4 |
|
MLYS
M
Mineralys Therapeutics, Inc.
Rodman David Malcom
• Officer • Chief Medical Officer
Other
2026-02-12
$6,857
|
||||||
| MLYS |
Mineralys Therapeutics, Inc.
|
Officer • Chief Medical Officer
Other
|
2026-02-12 | $6,857 | M | Form 4 |
|
MLYS
S
Mineralys Therapeutics, Inc.
Rodman David Malcom
• Officer • Chief Medical Officer
10b5-1 Sell
2026-02-12
$184,077x2
|
||||||
| MLYS |
Mineralys Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2026-02-12 | $184,077x2 | S | Form 4 |
|
MLYS
M
Mineralys Therapeutics, Inc.
Rodman David Malcom
• Officer • Chief Medical Officer
Other
2026-02-09
$34,736
|
||||||
| MLYS |
Mineralys Therapeutics, Inc.
|
Officer • Chief Medical Officer
Other
|
2026-02-09 | $34,736 | M | Form 4 |
|
MLYS
S
Mineralys Therapeutics, Inc.
Rodman David Malcom
• Officer • Chief Medical Officer
10b5-1 Sell
2026-02-09
$65,586
|
||||||
| MLYS |
Mineralys Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2026-02-09 | $65,586 | S | Form 4 |
|
MLYS
M
Mineralys Therapeutics, Inc.
Rodman David Malcom
• Officer • Chief Medical Officer
Other
2026-01-20
$6,423
|
||||||
| MLYS |
Mineralys Therapeutics, Inc.
|
Officer • Chief Medical Officer
Other
|
2026-01-20 | $6,423 | M | Form 4 |
|
MLYS
S
Mineralys Therapeutics, Inc.
Rodman David Malcom
• Officer • Chief Medical Officer
10b5-1 Sell
2026-01-20
$13,354
|
||||||
| MLYS |
Mineralys Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2026-01-20 | $13,354 | S | Form 4 |
|
MLYS
S
Mineralys Therapeutics, Inc.
Rodman David Malcom
• Officer • Chief Medical Officer
10b5-1 SellΔOwn -18.4%
2026-01-14
$370,645
|
||||||
| MLYS |
Mineralys Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 SellΔOwn -18.4%
|
2026-01-14 | $370,645 | S | Form 4 |
|
MLYS
M
Mineralys Therapeutics, Inc.
Rodman David Malcom
• Officer • Chief Medical Officer
Other
2026-01-13
$95,508x2
|
||||||
| MLYS |
Mineralys Therapeutics, Inc.
|
Officer • Chief Medical Officer
Other
|
2026-01-13 | $95,508x2 | M | Form 4 |
|
MLYS
S
Mineralys Therapeutics, Inc.
Rodman David Malcom
• Officer • Chief Medical Officer
10b5-1 SellΔOwn -11.1%
2026-01-13
$252,470
|
||||||
| MLYS |
Mineralys Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 SellΔOwn -11.1%
|
2026-01-13 | $252,470 | S | Form 4 |
|
MLYS
M
Mineralys Therapeutics, Inc.
Rodman David Malcom
• Officer • Chief Medical Officer
Other
2026-01-12
$6,856
|
||||||
| MLYS |
Mineralys Therapeutics, Inc.
|
Officer • Chief Medical Officer
Other
|
2026-01-12 | $6,856 | M | Form 4 |
|
MLYS
S
Mineralys Therapeutics, Inc.
Rodman David Malcom
• Officer • Chief Medical Officer
10b5-1 Sell
2026-01-12
$205,143
|
||||||
| MLYS |
Mineralys Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2026-01-12 | $205,143 | S | Form 4 |
|
MLYS
M
Mineralys Therapeutics, Inc.
Rodman David Malcom
• Officer • Chief Medical Officer
Other
2026-01-09
$34,720
|
||||||
| MLYS |
Mineralys Therapeutics, Inc.
|
Officer • Chief Medical Officer
Other
|
2026-01-09 | $34,720 | M | Form 4 |
|
MLYS
S
Mineralys Therapeutics, Inc.
Rodman David Malcom
• Officer • Chief Medical Officer
10b5-1 Sell
2026-01-09
$72,196
|
||||||
| MLYS |
Mineralys Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2026-01-09 | $72,196 | S | Form 4 |
|
MLYS
S
Mineralys Therapeutics, Inc.
Rodman David Malcom
• Officer • Chief Medical Officer
10b5-1 SellΔOwn -12.7%
2025-10-15
$445,982
|
||||||
| MLYS |
Mineralys Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 SellΔOwn -12.7%
|
2025-10-15 | $445,982 | S | Form 4 |
|
MLYS
S
Mineralys Therapeutics, Inc.
Rodman David Malcom
• Officer • Chief Medical Officer
10b5-1 Sell
2025-09-15
$409,266x2
|
||||||
| MLYS |
Mineralys Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2025-09-15 | $409,266x2 | S | Form 4 |